FDA | Press Releases
Follow
FDA Takes Action to Make a Treatment Available for Autism Symptoms
The U.S. Food and Drug Administration today initiated the approval of leucovorin calcium tablets for patients with cerebral folate deficiency (CFD), a neurological condition that affects folate (a vitamin essential for brain health) transport into the brain.
